Annual Total Liabilities
$75.77 M
+$30.81 M+68.52%
December 31, 2024
Summary
- As of March 13, 2025, AKRO annual total liabilities is $75.77 million, with the most recent change of +$30.81 million (+68.52%) on December 31, 2024.
- During the last 3 years, AKRO annual total liabilities has risen by +$49.34 million (+186.60%).
- AKRO annual total liabilities is now -40.37% below its all-time high of $127.07 million, reached on December 31, 2018.
Performance
AKRO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$75.77 M
-$3.45 M-4.35%
December 31, 2024
Summary
- As of March 13, 2025, AKRO quarterly total liabilities is $75.77 million, with the most recent change of -$3.45 million (-4.35%) on December 31, 2024.
- Over the past year, AKRO quarterly total liabilities has dropped by -$3.45 million (-4.35%).
- AKRO quarterly total liabilities is now -40.37% below its all-time high of $127.07 million, reached on December 31, 2018.
Performance
AKRO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AKRO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.5% | -4.3% |
| 3 y3 years | +186.6% | +186.6% |
| 5 y5 years | +706.8% | +706.8% |
AKRO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +186.6% | -4.3% | +224.5% |
| 5 y | 5-year | at high | +706.8% | -4.3% | +813.2% |
| alltime | all time | -40.4% | +1351.0% | -40.4% | +3052.0% |
Akero Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $75.77 M(+68.5%) | $75.77 M(-4.4%) |
| Sep 2024 | - | $79.22 M(+18.3%) |
| Jun 2024 | - | $66.98 M(+1.5%) |
| Mar 2024 | - | $65.99 M(+46.8%) |
| Dec 2023 | $44.97 M(+49.8%) | $44.97 M(-13.9%) |
| Sep 2023 | - | $52.20 M(+10.2%) |
| Jun 2023 | - | $47.37 M(+11.5%) |
| Mar 2023 | - | $42.47 M(+41.5%) |
| Dec 2022 | $30.01 M(+13.5%) | $30.01 M(-16.4%) |
| Sep 2022 | - | $35.90 M(-3.8%) |
| Jun 2022 | - | $37.30 M(+59.7%) |
| Mar 2022 | - | $23.35 M(-11.7%) |
| Dec 2021 | $26.44 M | $26.44 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $24.91 M(+39.3%) |
| Jun 2021 | - | $17.88 M(+54.1%) |
| Mar 2021 | - | $11.60 M(-20.7%) |
| Dec 2020 | $14.63 M(+55.7%) | $14.63 M(+7.7%) |
| Sep 2020 | - | $13.58 M(+30.6%) |
| Jun 2020 | - | $10.39 M(+25.3%) |
| Mar 2020 | - | $8.30 M(-11.6%) |
| Dec 2019 | $9.39 M(-92.6%) | $9.39 M(+39.0%) |
| Sep 2019 | - | $6.76 M(+41.4%) |
| Jun 2019 | - | $4.78 M(+98.8%) |
| Mar 2019 | - | $2.40 M(-98.1%) |
| Dec 2018 | $127.07 M(+2333.4%) | $127.07 M |
| Dec 2017 | $5.22 M | - |
FAQ
- What is Akero Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Akero Therapeutics?
- What is Akero Therapeutics annual total liabilities year-on-year change?
- What is Akero Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Akero Therapeutics?
- What is Akero Therapeutics quarterly total liabilities year-on-year change?
What is Akero Therapeutics annual total liabilities?
The current annual total liabilities of AKRO is $75.77 M
What is the all time high annual total liabilities for Akero Therapeutics?
Akero Therapeutics all-time high annual total liabilities is $127.07 M
What is Akero Therapeutics annual total liabilities year-on-year change?
Over the past year, AKRO annual total liabilities has changed by +$30.81 M (+68.52%)
What is Akero Therapeutics quarterly total liabilities?
The current quarterly total liabilities of AKRO is $75.77 M
What is the all time high quarterly total liabilities for Akero Therapeutics?
Akero Therapeutics all-time high quarterly total liabilities is $127.07 M
What is Akero Therapeutics quarterly total liabilities year-on-year change?
Over the past year, AKRO quarterly total liabilities has changed by -$3.45 M (-4.35%)